Yuan, F. (2026). Efficacy and safety of disitamab vedotin combined with toripalimab for cisplatin-refractory advanced penile cancer: A prospective single-center study (SAVE).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5034